tradingkey.logo

Biomerica Inc

BMRA
2.480USD
-0.230-8.49%
Close 11/04, 16:00ETQuotes delayed by 15 min
6.98MMarket Cap
LossP/E TTM

Biomerica Inc

2.480
-0.230-8.49%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Biomerica Inc

Currency: USD Updated: 2025-11-04

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Despite a weak stock market performance, the company shows strong fundamentals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Biomerica Inc's Score

Industry at a Glance

Industry Ranking
156 / 210
Overall Ranking
433 / 4616
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 0 analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Biomerica Inc Highlights

StrengthsRisks
Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two markets: clinical laboratories and point-of-care settings, including physicians’ offices and over-the-counter sales. It is focused on research and development efforts and is its patented diagnostic-guided therapy (DGT) product, developed on the in Foods technology platform. Its inFoods IBS product, uses a simple blood test to identify patient-specific foods that, when eliminated, may alleviate IBS symptoms such as pain, bloating, diarrhea, cramping, and constipation. Its hp+detect, a new diagnostic test for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract.
Growing
The company is in a growing phase, with the latest annual income totaling USD 5.31M.
Fairly Valued
The company’s latest PE is -1.61, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 90.65K shares, decreasing 76.07% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 21.13K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.18.

Financial Health

Currency: USD Updated: 2025-11-04

The company's current financial score is 6.71, which is lower than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is robust, and its operating efficiency is low. Its latest quarterly revenue reached 1.38M, representing a year-over-year decrease of 23.63%, while its net profit experienced a year-over-year decrease of 100.15%.

Score

Industry at a Glance

Previous score
6.71
Change
0

Financials

8.95

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data

Quality of Earnings

9.33

Operational Efficiency

3.66

Growth Potential

4.43

Shareholder Returns

7.18

Biomerica Inc's Company Valuation

Currency: USD Updated: 2025-11-04

The company’s current valuation score is 7.74, which is higher than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is -1.61, which is -64.84% below the recent high of -0.57 and -5185.02% above the recent low of -85.20.

Score

Industry at a Glance

Previous score
7.74
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 156/210
No Data

Earnings Forecast

Currency: USD Updated: 2025-11-04

There is no earnings forecast score for this company; the Healthcare Equipment & Supplies industry's average is 7.74.

Score

Industry at a Glance

Previous score
0.00
Change
0

Support & Resistance

No Data
No Data

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-04

The company’s current price momentum score is 5.49, which is lower than the Healthcare Equipment & Supplies industry's average of 6.77. Sideways: Currently, the stock price is trading between the resistance level at 2.98 and the support level at 2.22, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
5.01
Change
0.48

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(2)
Neutral(1)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.083
Sell
RSI(14)
31.595
Neutral
STOCH(KDJ)(9,3,3)
7.804
Oversold
ATR(14)
0.198
Low Volatility
CCI(14)
-200.103
Oversold
Williams %R
96.070
Oversold
TRIX(12,20)
-0.114
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
2.706
Sell
MA10
2.822
Sell
MA20
2.886
Sell
MA50
2.906
Sell
MA100
3.094
Sell
MA200
3.783
Sell

Institutional Confidence

Currency: USD Updated: 2025-11-04

The company’s current institutional recognition score is 3.00, which is lower than the Healthcare Equipment & Supplies industry's average of 6.39. The latest institutional shareholding proportion is 3.36%, representing a quarter-over-quarter decrease of 78.90%. The largest institutional shareholder is The Vanguard, holding a total of 21.13K shares, representing 0.72% of shares outstanding, with 28.67% decrease in holdings.

Score

Industry at a Glance

Previous score
3.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
Geode Capital Management, L.L.C.
21.66K
+10.68%
Moatazedi (David)
--
-100.00%
The Vanguard Group, Inc.
Star Investors
21.13K
+0.00%
BlackRock Institutional Trust Company, N.A.
18.64K
+0.01%
Coste (Catherine)
16.10K
+194.10%
Chin (Eric)
10.00K
--
1
2

Risk Assessment

Currency: USD Updated: 2025-11-04

The company’s current risk assessment score is 2.03, which is lower than the Healthcare Equipment & Supplies industry's average of 4.57. The company's beta value is 0.05. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Score

Industry at a Glance

Previous score
2.03
Change
0
Beta vs S&P 500 index
0.05
VaR
+8.23%
240-Day Maximum Drawdown
+69.90%
240-Day Volatility
+180.58%

Return

Best Daily Return
60 days
+15.84%
120 days
+17.28%
5 years
+101.71%
Worst Daily Return
60 days
-9.69%
120 days
-9.69%
5 years
-28.06%
Sharpe Ratio
60 days
-1.18
120 days
-0.75
5 years
-0.21

Risk Assessment

Maximum Drawdown
240 days
+69.90%
3 years
+92.83%
5 years
+96.67%
Return-to-Drawdown Ratio
240 days
-0.11
3 years
-0.33
5 years
-0.20
Skewness
240 days
+5.95
3 years
+4.94
5 years
+4.70

Volatility

Realised Volatility
240 days
+180.58%
5 years
+125.39%
Standardised True Range
240 days
+16.26%
5 years
+54.64%
Downside Risk-Adjusted Return
120 days
-137.76%
240 days
-137.76%
Maximum Daily Upside Volatility
60 days
+113.23%
Maximum Daily Downside Volatility
60 days
+65.05%

Liquidity

Average Turnover Rate
60 days
+4.00%
120 days
+2.30%
5 years
--
Turnover Deviation
20 days
+18.17%
60 days
-57.15%
120 days
-75.37%

Peer Comparison

Healthcare Equipment & Supplies
Biomerica Inc
Biomerica Inc
BMRA
4.44 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Castle Biosciences Inc
Castle Biosciences Inc
CSTL
8.67 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cencora Inc
Cencora Inc
COR
8.60 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
AxoGen Inc
AxoGen Inc
AXGN
8.58 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
TCMD
8.57 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings Inc
ZBH
8.54 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI